# Pluri Inc. (PLUR)

> Source: Nexqual · https://nexqual.com/PLUR · data as of 2026-10-15 20:00 UTC · cite as "Nexqual, Pluri Inc. (PLUR), nexqual.com/PLUR" · informational, not investment advice.

**Price:** USD 0.94 (+1.07% on the day) · last close of Oct 15, 2026; US market closed, not a live price. Prev close 0.94 · day 0.94–0.96 · 52w 0.85–4.87 · market cap null · NCM

## Key facts
- Analysts: None.
- Total return with dividends: 1Y -78.4% vs S&P 500 +18.1%; 5Y -95.5% vs S&P 500 +85.1%.

## Analysts
Consensus None.

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-16) | 5Y (from 2021-10-11) |
|---|---|---|
| Total return | -78.4% | -95.5% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | -78.5% | -46.2% |
| Volatility (annualized) | 71.5% | 66.3% |
| Max drawdown | -79.1% (Nov 2025→Oct 2026) | -95.8% (Nov 2021→Oct 2026) |

## Peers (Biotechnology)
RYTM (Rhythm Pharmaceuticals, Inc.) USD 87.97 +1.57% · BLTE (Belite Bio, Inc) USD 152.62 +0.49% · IOVA (Iovance Biotherapeutics, Inc.) USD 14.72 +1.52% · PRAX (Praxis Precision Medicines, Inc) USD 248.24 +2.01% · IONS (Ionis Pharmaceuticals, Inc.) USD 44.12 +4.11% · SYRE (Spyre Therapeutics, Inc.) USD 80.1 -0.44%

## More
Full page: https://nexqual.com/PLUR · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt